This particular study showed that an SUVmax ratio between tonsils >1.6 (62% sensitive, 100% specific) is highly suspicious and warrants biopsy.
When Should a Level IIB Neck Dissection Be Performed In Treatment of Head and Neck Squamous Cell Carcinoma?
In elective neck dissections for most HNSCC primary sites, level IIB nodes can be left intact, thus minimizing risk of damage to the spinal accessory nerve.
A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
Experts at the AAO-HNS Annual Meeting in Atlanta discuss checkpoint inhibitor success and ways to overcome resistance.
Head and Neck Chemo Delays Over 14 Weeks Increase Risk of Death
A look at the impact of delays in postoperative head and neck (HN) chemoradiotherapy on survival rates.
Women With HPV-Positive OPSCC Have Improved Overall Survival Rates
Sex does not play a prognostic role in HPV-negative OPSCC, and there are no differences in prognosis by race among HPV-positive or HPV-negative patients.
Diagnosing and Treating Depression in Head and Neck Cancer Patients
Survivors of Head and Neck Cancer Can Experience Long-Lasting Cognitive Impairment
Head and neck cancer survivors have neurocognitive sequelae up to two years after definitive chemoradiotherapy or radiation treatment.
Survivors of Head and Neck Cancers Experience Long-Lasting Cognitive Deficits
Survivors of head and neck cancers are at risk for delayed neurocognitive deficits for at least two years following radiotherapy or chemotherapy
When Should Surveillance Imaging Be Performed After Treatment for Head and Neck Cancer?
The majority of recurrences occur within the first two posttreatment years
Resistance Training During Chemoradiotherapy Safe for Patients with HNSCC
Progressive resistance training is also associated with high patient satisfaction
- 1
- 2
- 3
- …
- 5
- Next Page »